Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris
Clinical trial NCT03342573 · COMPLETED
Trial details
- NCT number
- NCT03342573
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2022-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.